Collectively these results further highlight the role of CXCL9 and CXCL10 in potentiating, not only anti-tumor CD8+ T cells but also anti-tumor CD4+ T cells, including cytotoxic CD4+ T cells. This evidence concerns the gene CD8A and neoplasm.